Efficacy, safety and cost-efficiency of adalimumab 80 mg every other week in previously intensified IBD patients under treatment with adalimumab 40 mg every week

R. Ferreiro-Iglesias, A. Jardi, A. Quiroga, I. Baston, J. Gonzalez, J. M. Giraldez, I. Zarra, M. J. Lamas, J. E. Dominguez-Munoz, M. Barreiro-de Acosta

Research output: Contribution to journalMeeting Abstract

Original languageEnglish
Pages (from-to)S390-S391
JournalJournal of Crohn's and Colitis
Volume13
Publication statusPublished - Mar 2019

Cite this

Ferreiro-Iglesias, R. ; Jardi, A. ; Quiroga, A. ; Baston, I. ; Gonzalez, J. ; Giraldez, J. M. ; Zarra, I. ; Lamas, M. J. ; Dominguez-Munoz, J. E. ; Barreiro-de Acosta, M. / Efficacy, safety and cost-efficiency of adalimumab 80 mg every other week in previously intensified IBD patients under treatment with adalimumab 40 mg every week. In: Journal of Crohn's and Colitis. 2019 ; Vol. 13. pp. S390-S391.
@article{ff6fe3baa6ab4cdbb43aba6d3b02e418,
title = "Efficacy, safety and cost-efficiency of adalimumab 80 mg every other week in previously intensified IBD patients under treatment with adalimumab 40 mg every week",
author = "R. Ferreiro-Iglesias and A. Jardi and A. Quiroga and I. Baston and J. Gonzalez and Giraldez, {J. M.} and I. Zarra and Lamas, {M. J.} and Dominguez-Munoz, {J. E.} and {Barreiro-de Acosta}, M.",
year = "2019",
month = "3",
language = "English",
volume = "13",
pages = "S390--S391",
journal = "Journal of Crohn's and Colitis",
issn = "1873-9946",
publisher = "Elsevier",

}

Ferreiro-Iglesias, R, Jardi, A, Quiroga, A, Baston, I, Gonzalez, J, Giraldez, JM, Zarra, I, Lamas, MJ, Dominguez-Munoz, JE & Barreiro-de Acosta, M 2019, 'Efficacy, safety and cost-efficiency of adalimumab 80 mg every other week in previously intensified IBD patients under treatment with adalimumab 40 mg every week', Journal of Crohn's and Colitis, vol. 13, pp. S390-S391.

Efficacy, safety and cost-efficiency of adalimumab 80 mg every other week in previously intensified IBD patients under treatment with adalimumab 40 mg every week. / Ferreiro-Iglesias, R.; Jardi, A.; Quiroga, A.; Baston, I.; Gonzalez, J.; Giraldez, J. M.; Zarra, I.; Lamas, M. J.; Dominguez-Munoz, J. E.; Barreiro-de Acosta, M.

In: Journal of Crohn's and Colitis, Vol. 13, 03.2019, p. S390-S391.

Research output: Contribution to journalMeeting Abstract

TY - JOUR

T1 - Efficacy, safety and cost-efficiency of adalimumab 80 mg every other week in previously intensified IBD patients under treatment with adalimumab 40 mg every week

AU - Ferreiro-Iglesias, R.

AU - Jardi, A.

AU - Quiroga, A.

AU - Baston, I.

AU - Gonzalez, J.

AU - Giraldez, J. M.

AU - Zarra, I.

AU - Lamas, M. J.

AU - Dominguez-Munoz, J. E.

AU - Barreiro-de Acosta, M.

PY - 2019/3

Y1 - 2019/3

M3 - Meeting Abstract

VL - 13

SP - S390-S391

JO - Journal of Crohn's and Colitis

JF - Journal of Crohn's and Colitis

SN - 1873-9946

ER -